---
title: "Vicat Reports Liquidity Contract Status with Kepler Cheuvreux as of Year-End 2025"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/273403930.md"
datetime: "2026-01-22T17:00:13.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273403930.md)
  - [en](https://longbridge.com/en/news/273403930.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273403930.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/273403930.md) | [English](https://longbridge.com/en/news/273403930.md)


# Vicat Reports Liquidity Contract Status with Kepler Cheuvreux as of Year-End 2025

Vicat SA reported on the status of its liquidity contract with Kepler Cheuvreux as of December 31, 2025. At period-end, the liquidity account held 9,539 shares and €3,892,143. During the second half of 2025, 3,879 buy transactions and 4,242 sell transactions were executed. The traded volumes reached 589,134 shares purchased for €37,628,667.2 and 583,055 shares sold for €37,424,565.1. The contract was transferred from Natixis Oddo BHF to Kepler Cheuvreux on April 1, 2025, with an initial balance of 17,619 shares and €3,172,168.3. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vicat SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW1001160663-en) on January 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

## 相關資訊與研究

- [20:49 ETThe $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step](https://longbridge.com/zh-HK/news/281274877.md)
- [3 Promising Penny Stocks With At Least $200M Market Cap](https://longbridge.com/zh-HK/news/281560342.md)
- [Kepler Capital  Reaffirms Their Sell Rating on H&R GmbH & Co. KGaA (0RRC)](https://longbridge.com/zh-HK/news/281452849.md)
- [Kepler Capital  upgrades SOL SPA (0NJP) to a Buy](https://longbridge.com/zh-HK/news/280893633.md)
- [Kepler Capital  Keeps Their Buy Rating on Enagas SA (0EBQ)](https://longbridge.com/zh-HK/news/281295824.md)